Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy.

Although both polyomavirus infection and T cell-mediated rejection (TCMR) are characterized by tubulointerstitial inflammation in the renal allograft, these conditions are treated with opposing therapeutic regimens. To gain more insight into the differences between antiviral and alloimmune responses, we performed a case-control study, in which we immunophenotyped the inflammatory infiltrates in renal biopsy specimens with BK polyomavirus-associated nephropathy (BKPyVAN) and specimens with TCMR. Compared with TCMR, BKPyVAN was diagnosed later after transplantation; therefore, BKPyVAN specimens showed more chronic damage than TCMR specimens showed. However, TCMR and BKPyVAN specimens had comparable levels of tubulointerstitial inflammation. Adjustment for confounders in various multivariable models revealed more blood dendritic cell antigen-1(+) (BDCA-1(+)) myeloid dendritic cells (mDCs) present during BKPyVAN (odds ratio, 2.31; 95% confidence interval, 1.03 to 5.16; P=0.04) than during TCMR. Double immunostaining for SV40 and BDCA-1 showed that, during BKPyVAN, BDCA-1(+) mDCs localized in proximity to the polyomavirus-infected tubular epithelial cells. We ensured that time of biopsy after transplantation was not a confounding factor by including additional specimens with late TCMR and protocol biopsy specimens matched for biopsy time. These additional specimens showed amounts of BDCA-1(+) mDCs comparable with amounts in the early TCMR specimens. These results suggest that BDCA-1(+) mDCs, known to be involved in the antiviral immune response during various viral infections, might have a pivotal role during BKPyVAN infection in the grafted kidney.

[1]  N. Thippeswamy Cellular Basis of Skin Allograft Rejection , 2017 .

[2]  N. Rogers,et al.  Dendritic cells and macrophages in the kidney: a spectrum of good and evil , 2014, Nature Reviews Nephrology.

[3]  J. Reeve,et al.  Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): Reproducibility of Polyomavirus Immunohistochemistry in Kidney Allografts , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  D. Rush,et al.  Banff 2013 Meeting Report: Inclusion of C4d‐Negative Antibody‐Mediated Rejection and Antibody‐Associated Arterial Lesions , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  Zhihong Liu,et al.  Immunophenotyping in BK Virus Allograft Nephropathy Distinct from Acute Rejection , 2013, Clinical & developmental immunology.

[6]  M. Mihatsch,et al.  Pathology of Resolving Polyomavirus‐Associated Nephropathy , 2013, American Journal of Transplantation.

[7]  P. Randhawa,et al.  BK Polyomavirus in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  B. Seliger,et al.  Predominance of TH2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity? , 2012, Human pathology.

[9]  T. Ninomiya,et al.  Putative Episodes of T-Cell–Mediated Rejection in Patients With Sustained BK Viruria but No Viremia , 2012, Transplantation.

[10]  I. T. Ten Berge,et al.  Interleukin‐17 positive cells accumulate in renal allografts during acute rejection and are independent predictors of worse graft outcome , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[11]  C. Macedo,et al.  The Polyomavirus BK Large T-Antigen-Derived Peptide Elicits an HLA-DR Promiscuous and Polyfunctional CD4+ T-Cell Response , 2011, Clinical and Vaccine Immunology.

[12]  M. Mihatsch,et al.  Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus‐Associated Nephropathy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  M. Mihatsch,et al.  Plasma cell infiltrates in polyomavirus nephropathy , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  B. Kaplan,et al.  Dendritic Cell Deficiency Associated With Development of BK Viremia and Nephropathy in Renal Transplant Recipients , 2010, Transplantation.

[15]  P. Randhawa,et al.  The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy , 2009, Modern Pathology.

[16]  G. Jhangri,et al.  Scoring Total Inflammation Is Superior to the Current Banff Inflammation Score in Predicting Outcome and the Degree of Molecular Disturbance in Renal Allografts , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  Hans H Hirsch,et al.  The decade of polyomavirus BK-associated nephropathy: state of affairs. , 2009, Transplantation.

[18]  G. Russ,et al.  Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection , 2009, Nephrology.

[19]  K. Smith,et al.  Tubular Basement Membrane Immune Deposits in Association with BK Polyomavirus Nephropathy , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  J. D. de Fijter,et al.  Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. , 2007, Kidney international.

[21]  G. Herrera,et al.  BK Polyomavirus in Renal Transplants: Role of Electron Microscopy and Immunostaining in Detecting Early Infection , 2007, Ultrastructural pathology.

[22]  M. Kuroda,et al.  Interplay of Cellular and Humoral Immune Responses against BK Virus in Kidney Transplant Recipients with Polyomavirus Nephropathy , 2006, Journal of Virology.

[23]  James W. Williams,et al.  Polyoma virus infection of renal allografts: relationships of the distribution of viral infection, tubulointerstitial inflammation, and fibrosis suggesting viral interstitial nephritis in untreated disease. , 2005, Human pathology.

[24]  C. Ryschkewitsch,et al.  Molecular Evaluation of BK Polyomavirus Nephropathy , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  G. Botti,et al.  Polyomavirus BK-specific immunity after kidney transplantation. , 2004, Transplantation.

[26]  H. Hirsch Polyomavirus BK Nephropathy: A (Re‐)emerging Complication in Renal Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  C. Chang,et al.  POLYOMA VIRUS INFECTION AFTER RENAL TRANSPLANTATION1: Use of Immunostaining as a Guide to Diagnosis , 2001, Transplantation.

[28]  F. Gudat,et al.  BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  E. Pettersson,et al.  CMV INFECTION, CLASS II ANTIGEN EXPRESSION, AND HUMAN KIDNEY ALLOGRAFT REJECTION , 1986, Transplantation.

[30]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[31]  J. D. de Fijter,et al.  Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome. , 2012, Kidney international.

[32]  C. M. van der Loos Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  A. Singer,et al.  Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. , 1992, Annual review of immunology.